Nymox Pharmaceutical Corporation
Country not established
- Devices
- 1
What Nymox Pharmaceutical Corporation makes
Nymox Pharmaceutical Corporation manufactures the NICALERT, a medical device designed for alerting or monitoring purposes in clinical or patient care settings. This product appears to serve as a signal or notification system, likely intended for use in environments requiring timely patient or procedural alerts.
The NICALERT is classified as a Class I device under FDA regulations and has undergone the 510(k) clearance process. The company is based in the United States, where its devices are registered and authorised for market distribution.
Catalogue
Nicalert Ref K021688
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Nymox Pharmaceutical Corporation have in the registry?
The registry currently lists 1 device for Nymox Pharmaceutical Corporation. Devices recorded under merged duplicate company entries are counted once.
Which registries list Nymox Pharmaceutical Corporation's devices?
Among its 1 most recently registered device, Nymox Pharmaceutical Corporation has devices listed in FDA 510(k) (1 device).
What risk classes do Nymox Pharmaceutical Corporation's devices fall under?
Among its 1 most recently registered device, the classes recorded for Nymox Pharmaceutical Corporation's devices are Class I. Each device page shows its own class and authorisation.
What are the newest devices from Nymox Pharmaceutical Corporation in the registry?
The most recently registered devices listed for Nymox Pharmaceutical Corporation include NICALERT.